Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Redwire | RDW | Nov 29, 2024 | 13.96 | +3.48 |
Redwood Trust | RWT | Nov 29, 2024 | 7.16 | -0.42 |
Redwood Trust | RWT-A | Nov 29, 2024 | 25.82 | +0.12 |
REE Automotive A | REE | Nov 29, 2024 | 7.73 | +0.39 |
Regal Rexnord | RRX | Nov 29, 2024 | 172.71 | +1.80 |
Regency Centers | REG | Nov 29, 2024 | 75.59 | -0.42 |
Regency Centers A Pref | REGCP | Nov 29, 2024 | 24.66 | +1.77 |
Regency Centers B Pref | REGCO | Nov 29, 2024 | 23.10 | +0.65 |
Regeneron Pharmaceuticals | REGN | Nov 29, 2024 | 750.22 | -0.62 |
REGENXBIO | RGNX | Nov 29, 2024 | 9.92 | -0.90 |
Regional Health Properties | RHE | Nov 29, 2024 | 1.74 | +1.98 |
Regional Health Properties A Pref | RHE-A | Nov 29, 2024 | 0.55 | 0.00 |
Regional Management | RM | Nov 29, 2024 | 30.53 | -1.01 |
Regions Financial | RF | Nov 29, 2024 | 27.26 | +0.04 |
Regions Financial B Pref | RF-B | Nov 29, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Nov 29, 2024 | 25.18 | +1.86 |
Regions Financial E Pref | RF-E | Nov 29, 2024 | 19.98 | +2.67 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Nov 29, 2024 | 26.40 | +1.30 |
Regis | RGS | Nov 29, 2024 | 25.01 | +2.67 |
Regulus Therapeutics | RGLS | Nov 29, 2024 | 1.61 | -1.83 |
Reinsurance Group of America | RGA | Nov 29, 2024 | 228.40 | -0.46 |
REIT Index ETF Vanguard | VNQ | Nov 29, 2024 | 98.16 | -0.45 |
Reitar Logtech | RITR | Nov 29, 2024 | 4.15 | 0.00 |
Rekor Systems | REKR | Nov 29, 2024 | 0.97 | +1.10 |
Relay Therapeutics | RLAY | Nov 29, 2024 | 4.70 | -2.08 |
Reliance | RS | Nov 29, 2024 | 321.24 | -0.42 |
Reliance Global | RELI | Nov 29, 2024 | 1.51 | -1.31 |
Relmada Therapeutics | RLMD | Nov 29, 2024 | 3.02 | +4.14 |
RELX ADR | RELX | Nov 29, 2024 | 47.08 | +0.06 |
Remitly Global | RELY | Nov 29, 2024 | 20.56 | -1.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.